ASOP Canada Statement on Proposed Regulations to Import Prescription Medicines from Canada
December 18, 2019
In response to today’s announcement by announcement by the Trump Administration and the proposed regulations to allow importation of prescription medicines, ASOP Canada issued the following statement.

ASOP Global Statement On HHS Drug Importation Announcement
December 18, 2019
In response to today’s announcement by Health and Human Services Secretary Alex Azar on the White House’s plan to allow U.S. consumers to import drugs from Canada, ASOP Global issued the following statement.

Black Women’s Health Imperative Joins ASOP Global As Newest Member
December 17, 2019
With a shared commitment to justice in health, ASOP Global is pleased to welcome BWHI as its newest member.

ASOP Canada and 14 Canadian Health Stakeholders Urge Prime Minister Trudeau, Health Canada to Protect Canadian Patients as U.S. Drug Importation Plans Accelerate
November 7, 2019
ASOP Canada and 14 Canadian organizations issued a letter to Prime Minister Justin Trudeau to express serious concern regarding U.S. drug importation plans

ASOP Global Statement on FDA/DEA Online Opioid Efforts
September 30, 2019
ASOP Global issued the following statement in response to the joint warning letters sent by the U.S. Food and Drug Administration and the U.S. Drug Enforcement Administration to online networks selling opioids.

ASOP Global Honors Rep. McKinley with Annual Patient Safety Champion Award
September 12, 2019

ASOP Global honored Rep. David McKinley (R-WV) with the organization’s annual ASOP Global Patient Safety Champion Award for his commitment to combatting the opioid epidemic and drug addiction.

Release of ASOP Global and LegitScript “The Chinese Internet Pharmacy Market Threat Assessment” Report
August 15, 2019
ASOP Global and LegitScript are pleased to release a new report titled “The Chinese Internet Pharmacy Market Threat Assessment.” ASOP Global contracted with LegitScript to prepare this study as part of the ASOP Global China Initiative, beginning in 2015.

ASOP GLOBAL Statement on HHS Drug Importation Announcement
July 31, 2019
The Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement in response to today’s announcement by Health and Human Services Secretary Alex Azar on the White House’s plan to allow U.S. consumers to import drugs from Canada.

ASOP Canada Urges Health Canada to Protect Canadian Drug Supply in Wake of U.S. Drug Importation Legislation, Along With 14 Other Canadian Health Stakeholders
July 26, 2019
ASOP Canada issued a letter to Canada’s Minister of Health Ginette Petitpas Taylor to express concern about U.S. state and federal legislation that permits the importation of Health Canada-approved medicines to the United States.

ASOP Global, Partnership for Safe Medicines: 300,000 Child Fatalities Annually Due To Counterfeit Medication
June 17, 2019
A peer-reviewed article in the American Journal of Tropical Medicine and Hygiene identifies the economic and human impact of counterfeit medicines. ASOP Global and PSM created a new infographic to help explain the deadly impact counterfeit medicines have, where they come from, and how they contribute to microbial resistance.

ASOP EU & Youth IGF Join Forces To Educate Youth Around the World of Fake Medicines Being Sold on the Internet
June 3, 2019
Buying medicines from unsafe sources can be dangerous and perhaps even deadly. More and more people turn to the Internet for goods and services, and medicines are not an exception to this growing trend.

ASOP Global Praises New USTR Notorious Markets Report
April 25, 2019
Patient safety advocates pleased that report recognizes pervasive threat posed by illegal online drug sellers and calls out bad actors.

ASOP Global Applauds FDA’s Commitment To Combating Illegal Online Drug Sales
April 5, 2019
The internet is awash with illegal prescription drug sellers claiming to be selling safe FDA- or Health Canada-approved medicines. For most consumers, finding a safe online pharmacy website can be like finding a needle in a haystack.

ASOP Global’s Statement on Congress’ proposed Affordable and Safe Prescription Drug Importation Act and the Safe and Affordable Drugs from Canada Act
January 11, 2019
ASOP Global has significant concerns about the risks of prescription drug importation and the dangers posed by counterfeit medicines.